| |
| |
|
| Insider
Information: |
Burke Willaim P |
| Relationship: |
Director |
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
392,609 |
|
|
Indirect Shares
|
10,000 |
|
|
| Direct
Value |
$2,733,356 |
|
|
|
Indirect Value
|
$70,000 |
|
|
| Total
Shares |
402,609 |
|
|
| Total
Value |
$2,803,356 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
6
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 56.1%
|
12.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP, Chief Financial O... |
2021-08-23 |
30,291 |
2016-10-25 |
0 |
Premium* |
|
|
Miromatrix Medical Inc. |
MIRO |
|
2023-12-13 |
0 |
2022-01-03 |
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Chief Financial Officer |
2023-03-01 |
356,318 |
2023-01-16 |
0 |
Premium* |
|
|
Axogen Inc |
AXGN |
Director |
2023-08-24 |
6,000 |
2023-08-23 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2016-10-25 |
4 |
A |
$34.21 |
$356,229 |
D/D |
10,413 |
10,413 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$232,476 |
D/D |
5,583 |
15,996 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,606 |
15,574 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,060 |
15,061 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,654 |
54,668 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,144 |
13,334 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
22,334 |
35,029 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2021-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
24,305 |
35,423 |
0 |
- |
|
| MIRO |
Miromatrix Medical Inc. |
Director |
– • – |
2022-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
36,117 |
36,117 |
0 |
- |
|
| MIRO |
Miromatrix Medical Inc. |
|
– • – |
2022-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
12,788 |
48,905 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2023-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
252,632 |
252,632 |
0 |
- |
|
| VRAY |
Viewray, Inc. |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
103,686 |
356,318 |
0 |
- |
|
| MIRO |
Miromatrix Medical Inc. |
|
– • – |
2023-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
54,201 |
134,356 |
0 |
- |
|
| AXGN |
Axogen Inc |
Director |
– • – |
2023-08-24 |
4 |
A |
$6.31 |
$37,860 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-25 |
4 |
AS |
$92.17 |
$616,341 |
D/D |
(6,687) |
14,604 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-11-08 |
4 |
AS |
$114.33 |
$1,492,692 |
D/D |
(13,056) |
12,001 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-01 |
4 |
AS |
$124.47 |
$901,198 |
D/D |
(7,164) |
13,014 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-08 |
4 |
AS |
$122.34 |
$2,318,343 |
D/D |
(18,950) |
35,718 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-09 |
4 |
AS |
$122.72 |
$2,815,079 |
D/D |
(22,704) |
13,014 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• – – |
2019-10-25 |
4 |
AS |
$119.87 |
$1,349,634 |
D/D |
(11,231) |
13,014 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• – – |
2019-10-28 |
4 |
AS |
$120.33 |
$138,981 |
D/D |
(1,155) |
11,859 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• – – |
2019-10-29 |
4 |
AS |
$122.69 |
$177,655 |
D/D |
(1,448) |
10,411 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-12 |
4 |
AS |
$89.29 |
$17,590 |
D/D |
(197) |
34,832 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-15 |
4 |
AS |
$87.71 |
$852,541 |
D/D |
(9,720) |
25,112 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-16 |
4 |
AS |
$90.36 |
$1,148,162 |
D/D |
(12,614) |
12,498 |
0 |
% |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
